Published in Clin Microbiol Infect on February 07, 2013
Rapid detection of Gram-positive organisms by use of the Verigene Gram-positive blood culture nucleic acid test and the BacT/Alert Pediatric FAN system in a multicenter pediatric evaluation. J Clin Microbiol (2013) 1.09
VRE and VSE Bacteremia Outcomes in the Era of Effective VRE Therapy: A Systematic Review and Meta-analysis. Infect Control Hosp Epidemiol (2015) 1.01
Superior sensitivity and decreased time to detection with the Bactec Peds Plus/F system compared to the BacT/Alert Pediatric FAN blood culture system. J Clin Microbiol (2013) 0.99
Biomarkers for sepsis: a review with special attention to India. Biomed Res Int (2014) 0.97
Time Is of the Essence: The Impact of Delayed Antibiotic Therapy on Patient Outcomes in Hospital-Onset Enterococcal Bloodstream Infections. Clin Infect Dis (2016) 0.90
Molecular epidemiology of enterococcal bacteremia in Australia. J Clin Microbiol (2014) 0.90
Risk factors associated with vancomycin-resistant enterococcus in intensive care unit settings in saudi arabia. Interdiscip Perspect Infect Dis (2013) 0.85
Control of the spread of vancomycin-resistant enterococci in hospitals: epidemiology and clinical relevance. Dtsch Arztebl Int (2013) 0.85
Whole-genome sequencing reveals transmission of vancomycin-resistant Enterococcus faecium in a healthcare network. Genome Med (2016) 0.82
Costs associated with implementation of a strict policy for controlling spread of highly resistant microorganisms in France. BMJ Open (2016) 0.78
Is a single positive blood culture for Enterococcus species representative of infection or contamination? Eur J Clin Microbiol Infect Dis (2014) 0.78
Rapid microbial sample preparation from blood using a novel concentration device. PLoS One (2015) 0.76
Magnitude of enterococcal bacteremia in trauma patients admitted for intensive trauma care: a tertiary care experience from South asian country. J Lab Physicians (2015) 0.75
Susceptibility of multidrug resistant clinical pathogens to a chlorhexidine formulation. J Prev Med Hyg (2015) 0.75
Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob Agents Chemother (2011) 4.21
In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother (2001) 2.79
Comparison of a multiplex reverse transcription-PCR-enzyme hybridization assay with conventional viral culture and immunofluorescence techniques for the detection of seven viral respiratory pathogens. J Clin Microbiol (2001) 2.41
The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin Infect Dis (2008) 2.39
A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl (2001) 2.34
Most individuals with treated blood pressures above target receive only one or two antihypertensive drug classes. Intern Med J (2013) 1.99
Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration. Antimicrob Agents Chemother (2005) 1.98
Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis. Clin Diagn Lab Immunol (1999) 1.97
Malaria acquired in Bali. Med J Aust (1995) 1.93
Direct detection of vanB2 using the Roche LightCycler vanA/B detection assay to indicate vancomycin-resistant enterococcal carriage--sensitive but not specific. J Antimicrob Chemother (2007) 1.88
Comparison of three PCR primer sets for identification of vanB gene carriage in feces and correlation with carriage of vancomycin-resistant enterococci: interference by vanB-containing anaerobic bacilli. Antimicrob Agents Chemother (2005) 1.81
Lifetime risk and projected population prevalence of diabetes. Diabetologia (2008) 1.73
Enterococcal vanB resistance locus in anaerobic bacteria in human faeces. Lancet (2001) 1.60
Is fosfomycin a potential treatment alternative for multidrug-resistant gram-negative prostatitis? Clin Infect Dis (2013) 1.60
Molecular characterization of vanB elements in naturally occurring gut anaerobes. Antimicrob Agents Chemother (2005) 1.58
Post-discharge surgical wound infection surveillance in a provincial hospital: follow-up rates, validity of data and review of the literature. ANZ J Surg (2001) 1.56
Phenotypic variation of Staphylococcus epidermidis isolated from a patient with native valve endocarditis. J Clin Microbiol (1992) 1.54
Multidisciplinary HIV adherence intervention: a randomized study. AIDS Patient Care STDS (2004) 1.54
Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA. Antimicrob Agents Chemother (2009) 1.50
Does the frequency of HIV and STI testing among men who have sex with men in primary care adhere with Australian guidelines? Sex Transm Infect (2010) 1.47
Pharmacokinetics in the elderly. Eur J Clin Pharmacol (1975) 1.46
A comparison of two dosing regimens of zidovudine in Thai adults with early symptomatic HIV infection. Conducting clinical HIV trials in South-East Asia. Aust N Z J Med (2000) 1.42
Candida infective endocarditis. Eur J Clin Microbiol Infect Dis (2008) 1.41
HIV in the suburbs. Med J Aust (1993) 1.38
A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. J Antimicrob Chemother (1996) 1.36
In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J Appl Bacteriol (1995) 1.34
Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiency. Clin Infect Dis (2010) 1.32
High-pressure liquid chromatographic method for the simultaneous quantitative analysis of propranolol and 4-hydroxypropranolol in plasma. J Chromatogr (1978) 1.30
High rates of fecal carriage of nonenterococcal vanB in both children and adults. Antimicrob Agents Chemother (2008) 1.29
Pharmacokinetics in the aged: a review. J Pharmacokinet Biopharm (1975) 1.28
The impact of pre-operative obesity on weight change and outcome in total knee replacement: a prospective study of 529 consecutive patients. J Bone Joint Surg Br (2010) 1.27
A quantitative assessment of the efficacy of surgical and N95 masks to filter influenza virus in patients with acute influenza infection. Clin Infect Dis (2009) 1.25
Random amplified polymorphic DNA and plasmid analyses used in investigation of an outbreak of multiresistant Klebsiella pneumoniae. J Clin Microbiol (1995) 1.25
A randomised controlled trial using mobile advertising to promote safer sex and sun safety to young people. Health Educ Res (2011) 1.21
In vitro activity of sparfloxacin (AT-4140, CI-978, PD 131501), a new quinolone antimicrobial agent. Diagn Microbiol Infect Dis (1991) 1.19
Control of endemic MRSA-what is the evidence? A personal view. J Hosp Infect (2004) 1.18
Psittacosis--a review of 135 cases. Med J Aust (1988) 1.17
Low-level vancomycin resistance in Staphylococcus aureus--an Australian perspective. Eur J Clin Microbiol Infect Dis (2005) 1.16
Helicobacter cinaedi bacteraemia: varied clinical manifestations in three homosexual males. Scand J Infect Dis (1996) 1.16
Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin. Med J Aust (2001) 1.15
Optimum treatment of staphylococcal infections. Drugs (1993) 1.13
Multiplicity of medication safety terms, definitions and functional meanings: when is enough enough? Qual Saf Health Care (2005) 1.13
Comparative study of selective chromogenic (chromID VRE) and bile esculin agars for isolation and identification of vanB-containing vancomycin-resistant enterococci from feces and rectal swabs. J Clin Microbiol (2008) 1.11
Pharmacokinetics of betamethasone in healthy adults after intravenous administration. Eur J Clin Pharmacol (1983) 1.10
Comparison of the Xpert methicillin-resistant Staphylococcus aureus (MRSA) assay, BD GeneOhm MRSA assay, and culture for detection of nasal and cutaneous groin colonization by MRSA. J Clin Microbiol (2009) 1.09
Antimicrobial resistance testing of Helicobacter pylori: a comparison of Etest and disk diffusion methods. Pathology (1997) 1.09
The relationship between obesity and the age at which hip and knee replacement is undertaken. J Bone Joint Surg Br (2008) 1.09
Vancomycin vintage: my favourite DRESS. Intern Med J (2015) 1.08
The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine. Drug Metab Rev (1996) 1.08
The pharmacokinetics of chlormethiazole following intravenous administration in the aged. Eur J Clin Pharmacol (1976) 1.08
It's time to move beyond trying to predict mortality using severity assessment tools in community-acquired pneumonia. Intern Med J (2014) 1.07
Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci. Antimicrob Agents Chemother (1992) 1.07
Whole genome sequencing in clinical and public health microbiology. Pathology (2015) 1.06
Simple, rapid and micro high-pressure liquid chromatographic method for the simultaneous determination of tolbutamide and carboxy tolbutamide in plasma. J Chromatogr (1978) 1.05
Nocardia infection in heart-lung transplant recipients at Alfred Hospital, Melbourne, Australia, 1989-1998. Clin Infect Dis (2000) 1.04
Lignocaine kinetics in cardiac patients and aged subjects. Br J Clin Pharmacol (1977) 1.04
Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia. Clin Microbiol Infect (2011) 1.03
Meperidine binding in maternal and fetal plasma. Clin Pharmacol Ther (1981) 1.02
Diagnosis and management of Staphylococcus aureus bacteraemia. Intern Med J (2005) 1.01
Researching breathlessness in palliative care: consensus statement of the National Cancer Research Institute Palliative Care Breathlessness Subgroup. Palliat Med (2009) 1.00
Antifungal prophylaxis in lung transplantation--a world-wide survey. Am J Transplant (2011) 0.99
Improved detection of vanB2-containing enterococcus faecium with vancomycin susceptibility by Etest using oxgall supplementation. J Clin Microbiol (2008) 0.99
A model for predicting the future incidence of coronary heart disease within percentiles of coronary heart disease risk. J Cardiovasc Risk (2001) 0.99
Fecal colonization with vancomycin-resistant enterococci in Australia. Emerg Infect Dis (2000) 0.97
Plasma level of chlormethiazole and two metabolites after oral administration to young and aged human subjects. Eur J Clin Pharmacol (1977) 0.97
Assessing the risk of tuberculosis infection among healthcare workers: the Melbourne Mantoux Study. Melbourne Mantoux Study Group. Med J Aust (2001) 0.96
Smoking and varicella pneumonia. J Infect (1988) 0.95
Animal bites and infections. Aust Fam Physician (1989) 0.95
Disposition of betamethasone in parturient women after intravenous administration. Eur J Clin Pharmacol (1983) 0.95
Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis. Clin Pharmacol Ther (2000) 0.94
Cost analysis of debridement and retention for management of prosthetic joint infection. Clin Microbiol Infect (2012) 0.94
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014. Intern Med J (2014) 0.94
Chronic relapsing salmonella osteomyelitis in an immunocompetent patient: case report and literature review. J Infect (2002) 0.94
Diazepam plasma binding in the perinatal period: influence of nonesterified fatty acids. Eur J Clin Pharmacol (1982) 0.94
Stereoselective plasma protein binding of ibuprofen enantiomers. Eur J Clin Pharmacol (1989) 0.94
The usage and costs of health services for HIV infection in Australia. AIDS (1995) 0.94
Vancomycin therapeutics and monitoring: a contemporary approach. Intern Med J (2013) 0.93
Home-based treatment of cellulitis with twice-daily cefazolin. Med J Aust (1998) 0.93
Severe dapsone syndrome due to weekly maloprim. Lancet (1988) 0.93
Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteraemia. Clin Microbiol Infect (2013) 0.93
Clostridium lavalense sp. nov., a glycopeptide-resistant species isolated from human faeces. Int J Syst Evol Microbiol (2009) 0.93
The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis. J Antimicrob Chemother (1999) 0.93
Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by trauma patients in the intensive care unit. J Hosp Infect (2004) 0.92
Risk factors for adverse cutaneous reactions associated with intravenous vancomycin. J Antimicrob Chemother (1997) 0.91
Potential survival gains in the treatment of myocardial infarction. Heart (2009) 0.91
Cost-effectiveness of prescribing statins according to pharmaceutical benefits scheme criteria. Med J Aust (2001) 0.90
A paired comparison of tuberculin skin test results in health care workers using 5 TU and 10 TU tuberculin. Thorax (2000) 0.90
High-performance liquid chromatographic determination of morphine and its 3- and 6-glucuronide metabolites: improvements to the method and application to stability studies. J Chromatogr (1991) 0.90
Gas chromatographic method for the quantitative determination of lidocaine and its metabolite monoethylglycinexylidide in plasma. J Chromatogr (1976) 0.89
Comparison of the bacterial isolates and antibiotic resistance patterns of elderly nursing home and general community patients. Intern Med J (2012) 0.89
Hospital-in-the-home care: is it worth the hassle? Med J Aust (1998) 0.89
Pharmacokinetics of gentamicin in very low birth weight preterm infants. Eur J Clin Pharmacol (1983) 0.88
Care of severe head injury patients in the Sarawak General Hospital: intensive care unit versus general ward. Med J Malaysia (2011) 0.88
Polymicrobial septicaemia with Pseudomonas aeruginosa and Streptococcus pyogenes following traditional tattooing. J Infect (1997) 0.88
Excretion of hydroxychloroquine in human milk. Br J Clin Pharmacol (1984) 0.88
Disposition of betamethasone in parturient women after intramuscular administration. Br J Clin Pharmacol (1984) 0.88
Staphylococcus aureus bacteraemia at Alice Springs Hospital, Central Australia, 2003-2006. Intern Med J (2012) 0.87